Item VI definition

Item VI. The USA Freedom Act requires us to collect information on the sources of funds. Please complete section 1, add the documents requested in section 2 only if funds did not come from an approved country (U.S. is approved), and complete section 3. Suitability Questionnaire: You must thoroughly complete the Suitability Questionnaire, in order for the Company and the Managing Dealer to make a determination whether this is a suitable investment for you.

Item VI. Payment to the Assignor on Funding Date: Item VII: Percentage Assigned: %

Item VI. This Item needs to be read by the investor and signed in acknowledgment.

Examples of Item VI in a sentence

• Item VI The number of shares or total amount of the securities outstanding for each class of securities authorized.

• Item VI - If the answer is yes, identify which has changed (Administrator, Medical Director, or Director of Nursing) and the date the change was made.

• Item VI: The number of shares or total amount of the securities outstanding for each class of securities authorized.

• Failure to apply treatment properly will result in recall treatment as listen in Item VI above.

• At the beginning of a due month, if the appropriate verification has not already been received, request that the client to submit a photocopy of the SSN card by the 15th of the month.2. If the client does not provide the SSN or card by the due date, take appropriate action as described in Item VI of this section.3. If the client does provide the SSN/card, file the photocopy of the card in Section 1 of the case file.

• Transferring a pass to a third party — whether sold or given free of charge — is not permitted and represents a severe violation of the Conditions of Participation, in accordance with Item VI of the General Section of the Conditions of Participation.

• Restrictions (in addition to those set forth in Subsection 5(d) or 5(e) of this Item VI) on the issuance of shares of the same series or of any other class or series.

• There shall be no arrearages with respect to the redemption of Cumulative Shares or Noncumulative Shares of any series from any sinking fund provided for shares of such series in accordance with the provisions of Section 1 of this Item VI.

• Shall, from time to time, make such redemptions of each series of Class F Shares as may be required to fulfill the requirements of any sinking fund provided for shares of such series at the applicable sinking fund redemption price fixed in accordance with the provisions of Section 1 of this Item VI; and shall in each case pay all accrued and unpaid dividends to the redemption date.

• Common Stock, Par Value $0.0001 Preferred Stock, Par Value $0.0001 Item VI: Number of shares or total amount of the securities outstanding for each class or securities authorized.

More Definitions of Item VI

Item VI. PREPARATION TIME

Item VI. The USA Freedom Act requires us to collect information on the sources of funds. Please complete section 1, add the documents requested in section 2 only if funds did not come from an approved country (U.S. is approved), and complete section 3. Item VII: You must thoroughly complete the Suitability Questionnaire in order for the Company and the Managing Dealer to make a determination whether this is a suitable investment for you. Item VIII: You must sign and date here. INSTRUCTIONS FOR PAYMENT Review and complete the Investor Representation and Suitability Questionnaire and deliver it to the email below, then send a wire transfer using the instructions below: Sxxxxx Securities, Inc. Email: oxxxxxxxx@xxxxxxxx0000.xxx If you prefer to send a wire transfer instead of a check, please mail or deliver your completed Investor Representation and Suitability Questionnaire to the address above and send the wire transfer using these instructions: Wiring Instructions Bank Name: Banc of California Bank Address: 3 XxxXxxxxx Xx, Xxxxx Ana, CA 92707 SWIFT Code: Routing Number: Account Name: Sxxxxx Securities Inc. Account Number: REF: Shuttle Pharma – [Investor Name] If you prefer to send a check instead of a wire transfer, please send a check to the account name and address below: Sxxxxx Securities, Inc. 6 Xxxxxxx, Xxxxx 000 Xxxxxx, XX 00000 If you need assistance, please contact: Contact: Bxxxxxx Xxxxxxxxxxxx Email: oxxxxxxxx@xxxxxxxx0000.xxx Phone: 900-000-0000 20 Exhibit A – Terms of the Offering Shuttle Pharmaceuticals Holdings, Inc. TERM SHEET SUMMARY This Term Sheet Summary (the “Term Sheet”) summarizes the terms on which you and other qualified accredited investors (the “Investors”) are invited to make an investment (the “Investment”) in Shuttle Pharmaceuticals Holdings, Inc. a Delaware corporation. This Term Sheet is merely a summary of the terms and provisions of the Subscription Agreement (the “Subscription Agreement”), the form of which will be provided to you. Accordingly, this Term Sheet is qualified in its entirety by reference, and is subject in all instances, to the terms and provisions of the Subscription Agreement. You are advised to carefully review the terms and provisions of the Subscription Agreement, as well as the risk factors attached thereto, before making a decision concerning the Investment.

Item VI. The USA Freedom Act requires us to collect information on the sources of funds. Please complete section 1, add the documents requested in section 2 only if funds did not come from an approved country (U.S. is approved), and complete section 3. Item VII: You must thoroughly complete the Suitability Questionnaire in order for the Company and the Managing Dealer to make a determination whether this is a suitable investment for you. Item VIII: You must sign and date here. INSTRUCTIONS FOR PAYMENT Review and complete the Investor Representation and Suitability Questionnaire and deliver it to the email below, then send a wire transfer using the instructions below: Sxxxxx Securities, Inc. Email: oxxxxxxxx@xxxxxxxx0000.xxx If you prefer to send a wire transfer instead of a check, please mail or deliver your completed Investor Representation and Suitability Questionnaire to the address above and send the wire transfer using these instructions: Wiring Instructions Bank Name: Banc of California Bank Address: 3 XxxXxxxxx Xx, Xxxxx Ana, CA 92707 SWIFT Code: BXXXXX00 Routing Number: 100000000 Account Name: Sxxxxx Securities Inc. Account Number: 2030626790 REF: Kairos Pharma – [Investor Name] If you prefer to send a check instead of a wire transfer, please send a check to the account name and address below: Sxxxxx Securities, Inc. 6 Xxxxxxx, Xxxxx 000 Xxxxxx, XX 00000 If you need assistance, please contact: Contact: Axxx Xxxxxx Email: oxxxxxxxx@xxxxxxxx0000.xxx Phone: 700-000-0000 INVESTOR REPRESENTATION & SUITABILITY QUESTIONNAIRE Please read all instructions of this Investor Representation and Suitability Questionnaire (this “Questionnaire”) carefully before filling out this Questionnaire. This is a legally binding document. If you need assistance, please call 900-000-0000 or by email at bxxxxxx@xxxxxxxx0000.xxx.

Item VI. The USA Freedom Act requires us to collect information on the sources of funds. Please complete section 1, add the documents requested in section 2 only if funds did not come from an approved country (U.S. is approved), and complete section 3. Item VII: You must thoroughly complete the Suitability Questionnaire, in order for the Company and the Managing Dealer to make a determination whether this is a suitable investment for you. Item VIII: You and must sign and date here. INSTRUCTIONS FOR PAYMENT Review and complete the Investor Representation & Suitability Questionnaire and deliver it to the email or address below along with payment for your investment. Email: xxxxxxxxx@xxxxxxxx0000.xxx Subject: Asset Entities Inc. – [Investor Name] Address: Boustead Securities, LLC 0 Xxxxxxx, Xxxxx 000 Xxxxxx, XX 00000 Bank Name: Banc of California Bank Address: 0 XxxXxxxxx Xxxxx Xxxxx Xxx, XX 00000 SWIFT Code: XXXXXX00 Routing #: 000000000 Account Name: Xxxxxx Securities Inc. Account #: 2030650369 REF / Notes: Asset Entities Inc. – [Investor Name] If you need assistance, please contact: Email: xxxxxxxxx@xxxxxxxx0000.xxx Phone: (000) 000-0000 INVESTOR REPRESENTATION & SUITABILITY QUESTIONNAIRE Please read all instructions of this Investor Representation and Suitability Questionnaire (this “Questionnaire”) carefully before filling out this Questionnaire. This is a legally binding document. If you need assistance, please call 000-000-0000 or by email at xxxxxxxxx@xxxxxxxx0000.xxx.

Item VI. Payment to the Assignor on Funding Date: Item VII: Percentage Assigned: ___% (Expressed as a percentage of the total aggregate Commitments of the Bank Group, carry out to 10 decimal places; upon effectiveness of the Assignment as provide in the Credit Agreement, this will constitute the Assignee’s “Pro Rata Share” Item VIII: Revised Percentage of the Assignor: ___% (carry out to 10 decimal places; upon effectiveness of the Assignment as provided in the Credit Agreement, this will constitute the Assignor’s “Pro Rata Share”) Schedule 1.1(a) Commitments and Percentages Bank: Initial Commitment: Percentage: U.S. Bank $ 35,000,000 23.333333333333 % JX Xxxxxx Cxxxx $ 22,500,000 15.000000000000 % Wxxxx Fargo $ 22,500,000 15.000000000000 % Hxxxxx Bank $ 15,000,000 10.000000000000 % Key Bank $ 15,000,000 10.000000000000 % Bank of America $ 10,000,000 6.666666666667 % Union Bank of California $ 15,000,000 10.000000000000 % Bank Hapoalim $ 7,500,000 5.000000000000 % Bank of the West $ 7,500,000 5.000000000000 % % Total: $ 150,000,000 100.000000000000 % Schedule 1.1(b) Material Subsidiaries (as of date of this Credit Agreement)

Item VI. Payment to the Assignor on Funding Date: Item VII: Percentage Assigned: ___% (Expressed as a percentage of the total aggregate Commitments of the Bank Group, carry out to 10 decimal places; upon effectiveness of the Assignment as provide in the Credit Agreement, this will constitute the Assignee’s “Pro Rata Share” Item VIII: Revised Percentage of the Assignor: ___% (carry out to 10 decimal places; upon effectiveness of the Assignment as provided in the Credit Agreement, this will constitute the Assignor’s “Pro Rata Share”) Schedule 1.1(a) Commitments and Percentages Bank: Initial Commitment: Percentage: U.S. Bank $ 40,000,000 40.00000 % JX Xxxxxx Chase $ 25,000,000 25.00000 % Wxxxx Fargo $ 25,000,000 25.00000 % Bank Hapoalim $ 10,000,000 10.00000 % Total: $ 100,000,000 100.00000 % Schedule 1.1(b) Material Subsidiaries (as of date of this Credit Agreement)